Although peripheral AC levels may not directly reflect brain-specific alterations, their role in systemic energy balance suggests an impact on central processes like mood regulation [18]
GLP-1 Agonists with SGLT-2 Inhibitors SGLT-2 inhibitors, used in diabetes treatment, may synergize with GLP-1 agonists to enhance weight loss and reduce cardiovascular risk
What about side effects and safety
Remember, acne is a systemic issue, and its largely a hormonal one, too
Use for non-HIV indications including off-label use for general visceral fat reduction, metabolic syndrome, or body composition is not FDA-approved and is considered off-label or research use
This practice not only minimizes burning but also prevents lipodystrophy (fat atrophy or hypertrophy) that can develop from repeated injections in identical locations